SLC25A19 and colorectal carcinoma: Additionally, we noted a positive correlation between the upregulation of SLC25A19 and age, sex, lymph node positivity, lymph node invasion, stage, and lymphatic metastasis, indicating that SLC25A19 could potentially serve as a novel therapeutic target for CRC treatment.